| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID1420: Nintedanib for treating interstitial lung disease caused by systemic sclerosis |
|
Medicine details |
|
| Medicine name | nintedanib (Ofev®) |
| Formulation | capsule |
| Reference number | 3056 |
| Indication | In adults for the treatment of systemic sclerosis associated interstitial lung disease |
| Company | Boehringer Ingelheim Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 23/05/2020 |
| NICE guidance | ID1420: Nintedanib for treating interstitial lung disease caused by systemic sclerosis |